These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26384280)

  • 21. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy.
    Lazor R; Etienne-Mastroianni B; Khouatra C; Tazi A; Cottin V; Cordier JF
    Thorax; 2009 Mar; 64(3):274-5. PubMed ID: 19252036
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].
    Grau J; Ribera JM; Tormo M; Indiano JM; Vercher J; Sandoval V; Ramírez G; Sastre A; Flores E; García-Conde J
    Med Clin (Barc); 2001 Mar; 116(9):339-42. PubMed ID: 11333766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
    Stine KC; Saylors RL; Williams LL; Becton DL
    Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cladribine therapy in adults with advanced Langerhans cell histiocytosis.
    Schini M; Makras P; Kanakis G; Voulgarelis M; Kaltsas G
    Leuk Lymphoma; 2013 Jul; 54(7):1541-3. PubMed ID: 23101752
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
    Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
    Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan.
    Taniguchi M; Sakamoto K; Shioda Y; Doi T; Kudo K; Fujino H; Kudo K; Morimoto A
    Int J Hematol; 2021 Mar; 113(3):461-463. PubMed ID: 33564966
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cladribine treatment in patients with pulmonary Langerhans cell histiocytosis.
    Radzikowska E; Wakuliński J; Langfort R; Dziuk M; Wesołowski S; Błasińska K
    Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37850728
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
    Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
    Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract.
    Mayumi A; Imamura T; Sakamoto K; Ota T; Osone S; Usami I; Hosoi H
    Int J Hematol; 2019 Dec; 110(6):756-762. PubMed ID: 31350665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clofarabine in refractory Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
    Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine.
    Eckstein OS; Bernhardt MB; Hood CG; Karri V; Kralik SF; McClain KL
    Pediatr Hematol Oncol; 2023; 40(5):497-505. PubMed ID: 36625721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
    Uppuluri R; Ramachandrakurup S; Balaji R; Subburaj D; Bakane A; Raj R
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e74-e78. PubMed ID: 28099396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
    Baumann M; Cerny T; Sommacal A; Koeberle D
    Hematol Oncol; 2012 Jun; 30(2):101-4. PubMed ID: 21732400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
    Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
    Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
    Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
    Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
    Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
    Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.